Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-28

FDA Approved: RANOLAZINE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries' generic ranolazine under an original application, expanding access to this antianginal therapy for chronic angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)